These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 32736685
1. Peroxiredoxin I deficiency increases keratinocyte apoptosis in a skin tumor model via the ROS-p38 MAPK pathway. Han YH, Zhang YQ, Jin MH, Jin YH, Qiu MY, Li WL, He C, Yu LY, Hyun JW, Lee J, Yoon DY, Sun HN, Kwon T. Biochem Biophys Res Commun; 2020 Aug 27; 529(3):635-641. PubMed ID: 32736685 [Abstract] [Full Text] [Related]
2. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Song IS, Kim SU, Oh NS, Kim J, Yu DY, Huang SM, Kim JM, Lee DS, Kim NS. Carcinogenesis; 2009 Jul 27; 30(7):1106-14. PubMed ID: 19406930 [Abstract] [Full Text] [Related]
3. REGγ is critical for skin carcinogenesis by modulating the Wnt/β-catenin pathway. Li L, Dang Y, Zhang J, Yan W, Zhai W, Chen H, Li K, Tong L, Gao X, Amjad A, Ji L, Jing T, Jiang Z, Shi K, Yao L, Song D, Liu T, Yang X, Yang C, Cai X, Xu W, Huang Q, He J, Liu J, Chen T, Moses RE, Fu J, Xiao J, Li X. Nat Commun; 2015 Apr 24; 6():6875. PubMed ID: 25908095 [Abstract] [Full Text] [Related]
4. Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. Hess A, Wijayanti N, Neuschäfer-Rube AP, Katz N, Kietzmann T, Immenschuh S. J Biol Chem; 2003 Nov 14; 278(46):45419-34. PubMed ID: 12960165 [Abstract] [Full Text] [Related]
6. Advanced oxidative protein products induced human keratinocyte apoptosis through the NOX-MAPK pathway. Sun B, Ding R, Yu W, Wu Y, Wang B, Li Q. Apoptosis; 2016 Jul 14; 21(7):825-35. PubMed ID: 27155970 [Abstract] [Full Text] [Related]
9. Peroxiredoxin V Silencing Elevates Susceptibility to Doxorubicin-induced Cell Apoptosis via ROS-dependent Mitochondrial Dysfunction in AGS Gastric Cancer Cells. Jin YZ, Gong YX, Liu Y, Xie DP, Ren CX, Lee SJ, Sun HN, Kwon T, Xu DY. Anticancer Res; 2021 Apr 14; 41(4):1831-1840. PubMed ID: 33813388 [Abstract] [Full Text] [Related]
10. Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-κB-mediated iNOS induction and microglial activation. Kim SU, Park YH, Min JS, Sun HN, Han YH, Hua JM, Lee TH, Lee SR, Chang KT, Kang SW, Kim JM, Yu DY, Lee SH, Lee DS. J Neuroimmunol; 2013 Jun 15; 259(1-2):26-36. PubMed ID: 23602274 [Abstract] [Full Text] [Related]
12. Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals. Ma D, Warabi E, Yanagawa T, Kimura S, Harada H, Yamagata K, Ishii T. Oral Oncol; 2009 Dec 15; 45(12):1037-43. PubMed ID: 19692293 [Abstract] [Full Text] [Related]
14. Apoptosis signal regulating kinase-1 connects reactive oxygen species to p38 MAPK-induced mitochondrial apoptosis in UVB-irradiated human keratinocytes. Van Laethem A, Nys K, Van Kelst S, Claerhout S, Ichijo H, Vandenheede JR, Garmyn M, Agostinis P. Free Radic Biol Med; 2006 Nov 01; 41(9):1361-71. PubMed ID: 17023263 [Abstract] [Full Text] [Related]
15. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. Kim SY, Kim TJ, Lee KY. FEBS Lett; 2008 Jun 11; 582(13):1913-8. PubMed ID: 18501712 [Abstract] [Full Text] [Related]
19. Knockdown of peroxiredoxin V increases glutamate‑induced apoptosis in HT22 hippocampal neuron cells. Shen GN, Liu L, Feng L, Jin Y, Jin MH, Han YH, Jin CH, Jin YZ, Lee DS, Kwon TH, Cui YD, Sun HN. Mol Med Rep; 2018 Jun 11; 17(6):7827-7834. PubMed ID: 29620243 [Abstract] [Full Text] [Related]